Friday, July 17, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Micron’s Earnings Test: Can the Memory Chip Giant Live Up to Its Own Lofty Forecast?

Jackson Burston by Jackson Burston
May 28, 2026
in Uncategorized
0
Micron Stock
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

Barclays has more than quadrupled its price target on Micron in the space of six months, from $275 in December to $1,175 today. Analyst Tom O’Malley points to a fundamental shift: the chipmaker has replaced short-term contracts with multi-year volume agreements, giving it rare visibility in an industry infamous for violent boom-bust cycles. That newfound predictability helped propel Micron into the $1 trillion market-cap club this week, alongside Samsung and SK Hynix – a trifecta of memory-chip giants all crossing the same threshold within days. Micron’s own journey was the most dramatic: a single-day surge of 19% on Tuesday, the fifth-best trading session in its history.

All eyes now turn to June 24, when Micron reports fiscal third-quarter results. The company’s own forecast sets an extraordinarily high bar: revenue of $33.5 billion, a gross margin near 81% and adjusted earnings per share of $19.15. Those figures would represent a leap from the prior quarter’s $23.9 billion in sales and 74.9% gross margin, as well as a dramatic year-over-year acceleration. The stock, after soaring more than eightfold over the past twelve months from a 52‑week low of €83.25 to a record €799, has eased slightly to €783.10. The forward price-to-earnings ratio of roughly 44 leaves no margin for error – a gamble on flawless execution.

Investors will scrutinise more than the headline numbers. Did Micron hit the midpoint of its revenue guidance? Is the gross margin truly sustainable at 81%? And what about free cash flow, which reached $6.9 billion in the second quarter against a cash pile of $16.7 billion? The company is also buying back shares and paying a quarterly dividend of $0.15; the call is likely to address whether those programmes will continue amid heavy capital spending on new fabrication capacity. The report serves as the first official check on whether the AI-driven hunger for memory chips is translating into hard profit.

Should investors sell immediately? Or is it worth buying Micron?

The broader industry backdrop only amplifies the stakes. Gartner forecasts DRAM prices will rise 125% in 2026 and NAND flash prices by 234%, with no relief expected until at least the end of 2027. Barclays estimates the global NAND market alone will hit $174 billion next year, as hyperscalers scramble to lock in capacity before costs climb further. The structural imbalance between supply and demand is so pronounced that Barclays expects it to persist through 2027.

Analyst expectations are already stratospheric. For the current quarter, the sell-side is modelling earnings growth of 906% year over year. UBS goes further, projecting that Micron will generate more than $400 billion in free cash flow between 2027 and 2029. Yet despite the rally, the stock’s forward P/E on consensus estimates sits at under ten – a valuation that seems almost modest given the narrative. Goldman Sachs, in a related move, raised its year‑end target for the S&P 500 to 8,000 points, arguing that AI‑infrastructure companies such as Nvidia and Micron will contribute roughly half of the index’s earnings growth this year.

The June 24 report will either validate the memory‑chip supercycle or test the limits of AI euphoria. Micron has laid out a roadmap that few would have believed two years ago. Now the market gets to see whether the numbers match the vision.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from July 17 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 17.

Micron: Buy or sell? Read more here...

Tags: Micron
Jackson Burston

Jackson Burston

Related Posts

ABB Stock
European Markets

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

July 17, 2026
Allianz Stock
Analysis

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

July 17, 2026
Caterpillar Stock
Analysis

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Next Post
Take-Two Stock

Take-Two’s Record Guidance Hinges on November as Recurring Revenue Buys Time

Partners Group Stock

Partners Group Bets on Patient Capital with Total Return Strategy as $450B AUM Target Looms

Salesforce Beats, Sells Off: The AI Software Reckoning Begins

Salesforce Beats, Sells Off: The AI Software Reckoning Begins

Recommended

Unitedhealth Stock

Could Warren Buffett’s Investment Signal a Turnaround for UnitedHealth?

11 months ago
Amazon Stock

Amazon’s AI Ambitions Offset by Logistics Headwinds

4 months ago
Commerzbank Stock

Commerzbank’s Standalone Strategy Intensifies as BaFin Clamps Down on UniCredit

3 months ago
TKMS Stock

TKMS: A Naval Giant’s Fate Hinges on Three Critical Weeks

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

SanDisk’s Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

From Cost Center to Cloud: Meta’s Infrastructure Avalanche Meets a Skeptical Analyst

Trending

ABB Stock
European Markets

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

by Rodolfo Hanigan
July 17, 2026
0

ABB is in the midst of a sweeping portfolio overhaul that few investors expected to come at...

Allianz Stock

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

July 17, 2026
Caterpillar Stock

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit
  • Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply
  • Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com